We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Depressive and anxiety symptoms among Japanese cancer survivors: Japan cancer survivorship research project.
- Authors
Endo, Motoki; Matsui, Kentaro; Akaho, Rie; Mitsui, Kiyomi; Yan, Yan; Imai, Yuya; Ueda, Yuito; Muto, Go; Deshpande, Gautam A.; Terao, Yasuhisa; Takeda, Satoru; Saito, Mitsue; Hayashi, Kazuhiko; Nishimura, Katsuji; Tanigawa, Takeshi
- Abstract
<bold>Background: </bold>This study aimed to clarify predictors of depressive symptoms and anxiety symptoms after cancer diagnosis among Japanese cancer survivors (CSs).<bold>Methods: </bold>As part of a Japanese cancer survivorship research project commissioned by the Ministry of Health, Labour and Welfare (MHLW) of Japan, we conducted a web-based nationwide survey of CSs in 2018. We analyzed the risk factors for depressive and anxiety symptoms, as measured by the Hospital Anxiety and Depression Scale Japanese version (HADS).<bold>Results: </bold>Of 1,234 Japanese CSs, mean score of HADS-depression and HADS-anxiety were 4.08 and 4.78, respectively. At the time of the study, the number of CSs with symptoms of depression and anxiety were 111 (9.0%) and 269 (21.8%), respectively. After multivariable analysis, CSs ≥ 60 years old (reference: ≤ 39 years old, odds ratios (OR): 0.39, 95%CI: 0.17-0.90) and those ≥ 10 years from cancer diagnosis (reference: 0-4 years, OR: 0.55, 95%CI: 0.32-0.96) had lower odds for depressive symptoms. And CSs ≥ 60 years old (reference: ≤ 39 years old, OR: 0.27, 95%CI: 0.15-0.49) and those ≥ 10 years from cancer diagnosis (reference: 0-4 years, OR: 0.62, 95%CI: 0.42-0.90) also had lower odds for anxiety symptoms. CSs who received chemotherapy (OR: 1.56, 95%CI: 1.10-2.20) had higher odds for anxiety symptoms.<bold>Conclusions: </bold>Based on manifestation of symptoms, CSs who were younger, closer to the time of cancer diagnosis, had advanced-staged cancer, or received chemotherapy may be at higher risk for depressive or anxiety symptoms. Those CSs who have higher risk for depression and anxiety symptoms, should be followed-up more carefully for better cancer survivorship, by medical professionals, companies, and society.
- Subjects
JAPAN; MENTAL depression; CANCER survivors; CANCER research; CANCER diagnosis; ANXIETY
- Publication
BMC Cancer, 2022, Vol 22, Issue 1, p1
- ISSN
1471-2407
- Publication type
Article
- DOI
10.1186/s12885-022-09215-x